• Bloomberg

  • SHARE

Takeda Pharmaceutical Co. owes $6.5 million in damages to a California man who said Asia’s largest drugmaker failed to warn consumers its Actos diabetes drug could cause cancer, a jury said in the first of more than 3,000 lawsuits over the medication to go to trial.

Jurors in state court in Los Angeles deliberated for more than five days before finding Osaka-based Takeda didn’t provide adequate bladder-cancer warnings to Jack Cooper and his doctors about Actos.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)